Tofacitinib citrate intermediate impurity and preparation method thereof

The invention provides a preparation method of a tofacitinib citrate intermediate impurity (compound I), which comprises the following steps: adding sodium hydride in batches at 0-10 DEG C, heating the material to room temperature after adding, and then slowly heating the material to 50-70 DEG C for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JIE YUANPING, LI HENGTAO, WU XIHAN, DENG LUJIANG
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention provides a preparation method of a tofacitinib citrate intermediate impurity (compound I), which comprises the following steps: adding sodium hydride in batches at 0-10 DEG C, heating the material to room temperature after adding, and then slowly heating the material to 50-70 DEG C for reaction, wherein the molar ratio of the compound II to the sodium hydride is 1:0.4-1:0.6, and the reaction time is 30-40 hours. In the post-treatment process, water or isopropanol is dropwise added for quenching, and after a crude product is obtained, ethyl acetate and n-heptane are used for recrystallization. The quality of the tofacitinib citrate can be better controlled due to the discovery of the impurity. 本发明提供了一种枸橼酸托法替布中间体杂质(化合物I)的制备方法,在0~10℃下,将氢化钠分批加入,加完后升温至室温,然后缓慢升温至50~70℃反应。化合物II与氢化钠摩尔比范围为1∶0.4~1∶0.6,反应时间为30~40小时。后处理的过程中,先滴加水或者异丙醇淬灭,得到粗品后,用乙酸乙酯和正庚烷进行重结晶。这个杂质的发现可以更好地控制枸橼酸托法替布的质量。